Health & Biotech · Jul 1, 2026, 2:15 AM EDT
Maccabi Healthcare ServicesThe second-largest of Israel's four statutory health funds, covering roughly a quarter of the population and home to the KSM Research Institute medica…
Israel Real Economy · 27 stories · Updated Aug 14, 2026
Health & Biotech — Page 3
Latest in Health & Biotech
27 stories
Lead storyHealth & Biotech · Oct 21, 2026, 9:00 AM EDT
Who Owns Israel's Pharmacy Chains? Super-Pharm and Be
Leon Koffler controls Super-Pharm, Union Group's Horesh holds about a third, and Shufersal owns Be. Who owns Israel's pharmacy chains and why it matters.
Read →Reference and analysis
Long-form reference entries in Health & Biotech
- Yeda's Copaxone — The Best Academic License in History
The Weizmann Institute's tech transfer arm earned more than $1.5bn in royalties on a single multiple sclerosis drug. The…
- Weizmann and the Yeda Model
Yeda — the Weizmann Institute's tech-transfer arm — is the prototype Israeli university commercialisation vehicle. Its l…
- The Israeli Hospital Innovation Engine: Sheba, Hadassah, Ichilov & the Commercial Translation Layer
- Sheba ARC: The Global Innovation Arm and Sheba Medical Center's International Position
Articles
Page 3 of 3
Health & Biotech · Jul 2, 2026, 2:15 AM EDT
Sal HaTziyud (Health Services Basket)The legally defined package of medical services, drugs, and devices that every Israeli resident is entitled to receive under the country's 1995 Nation…
Health & Biotech · Jul 5, 2026, 2:15 AM EDT
Meuhedet Health Services: Israel's Third-Largest Statutory Health FundMeuhedet Health Services is Israel's third-largest statutory health fund with 1.3 million members. It was founded in 1974 through a merger of Amamit a…
Health & Biotech · Jun 10, 2026, 6:17 AM EDT
Israeli Biotech's Anti-Blockbuster Bet — And Why It WorksIsrael has 1,800 life-sciences companies and almost no blockbuster drugs. That's not a weakness. That's the strategy — devices, AI health, Weizmann li…
Health & Biotech · Jun 3, 2026, 2:13 AM EDT
Israel's Biotech Decade Has Gone InstitutionalIsrael's biotech decade is no longer a frontier story — it's a category. $1.2 billion a year in health-tech funding, AI-native drug discovery platform…
Health & Biotech · Jun 4, 2026, 1:00 AM EDT
Israel's $25 Billion Buyer Class You Can't SeeIsrael's four HMOs control more than $25 billion in annual healthcare procurement. Their decisions on AI, pharma, diagnostics, and digital health shap…
Health & Biotech · Jun 9, 2026, 9:13 AM EDT
The Combat-Medicine DividendIsrael's grimmest input — a long history of war injury — has become a real engine of medical innovation. It is an uncomfortable fact, and an honest ac…
Health & Biotech · Jun 6, 2026, 9:13 AM EDT
The Hospital as Startup FactoryIsrael's most distinctive contribution to medicine is not a drug or a device. It is a model: the hospital itself turned into a co-development engine t…
Health & Biotech · May 31, 2026, 5:20 PM EDT
The Four FundsEvery Israeli belongs to one of four health funds: Clalit, Maccabi, Meuhedet, or Leumit. Each fund acts as an insurer, clinic, and pharmacy.